Senior R&D Quality Officer, Product Development Quality Assurance
AbbVie
- Location
- Irvine, CA, United States
- Employment
- Full Time
- Work model
- On-Site
- Level
- Senior
- H-1B history
- 94 approvals (FY2023)
- Posted
- 3h ago
About this role
Company Description
About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube.
Job Description
Purpose This position is within the Product Development Quality Assurance (PDQA) organization and supports the timely review and disposition of batch documentation to help ensure uninterrupted clinical supply, advance the R&D pipeline, and maintain compliance with AbbVie standards and global GMP requirements. The role supports New Biological Entities (NBE), New Chemical Entities (NCE), and Advanced Therapy Medicinal Products (ATMP) across all phases of development, partnering with Third Party Manufacturers (TPM), AbbVie commercial manufacturing sites, and cross-functional teams to ensure drug substance and drug product for clinical use meet quality and regulatory requirements.
Job Description
The Senior R&D Quality Officer is responsible for GMP batch documentation review and clinical supply disposition for NBE, NCE, and ATMP development programs. This role applies deep QA expertise and GMP knowledge to ensure quality oversight of manufacturing activities at TPMs and AbbVie commercial sites in accordance with global GMP requirements and AbbVie quality standards. The role also provides strategic quality leadership, cross-functional influence, and support for development and mentoring of junior PDQA quality staff. Key responsibilities include, but are not limited to: Works effectively in a global environment, supporting the global Quality Assurance organization and cross-functional teams across multiple regions and time zones. Review and approve batch manufacturing records (master and executed) and quality documentation for drug substance and drug product clinical supply batches at TPMs and AbbVie sites; make batch disposition and quality release decisions per SOPs, quality agreements, and GMP requirements; and apply risk-based quality assessments to support timely, defensible decisions and clinical supply continuity. Assess the quality impact of manufacturing changes affecting drug substances or drug products, with a focus on NBE/NCE/ATMP clinical supply programs. Author, review, and approve quality system documents, including SOPs and manufacturing instructions, to ensure accuracy and sustained GMP compliance. Lead deviation and investigation activities for documentation errors, batch discrepancies, and process failures; author, review, and approve deviation/change control plans, exception documentation, and CAPA plans; drive thorough root cause analysis, timely corrective action, and sustained batch record right-first-time improvements. Support the development of quality agreements with TPMs and internal manufacturing sites; lead TPM and supplier quality oversight activities, including escalation, and qualification strategy discussions. Provide quality approvals in materials management and electronic quality systems, ensuring traceability, data integrity, and compliance across the clinical supply chain. Partner cross-functionally with Clinical Drug Supply Management, Development Sciences, and Operations to identify and mitigate quality and manufacturing risks early in the batch lifecycle, protect batch availability, and ensure clinical supply continuity; lead project team efforts to drive timely, risk-based resolution strategies. Generate, monitor, and report key PDQA quality metrics including batch documentation cycle times, aging documents, deviation trends, repeat deviations, CAPA effectiveness, and